Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Clinical Rheumatology|January 15, 2014
Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in JapanHirotaka Katada, Naoichiro Yukawa, Hisashi Urushihara, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|November 26, 2019
[Effects of polypharmacy and anticholinergic/sedative drugs on the physical/cognitive/mental related outcomes of community-dwelling elderly people: The Kawasaki Wellbeing Project]Asahi Tanaka, Yasumichi Arai, Takumi Hirata, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 23, 2021
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studiesToshiki Fukasawa, Hayato Takahashi, Kunihiko Takahashi, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Transaction Cost Analysis of the New Drug Application Process: A Case Study of a Multinational Pharmaceutical Company in JapanShota Hamada, Akiko Shibata, Hisashi Urushihara, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2015
Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancerYusuke Narita, Yukiko Matsushima, Takeru Shiroiwa, et al.
Plos One|June 7, 2014
Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010Sachiko Nakaoka, Tatsuro Ishizaki, Hisashi Urushihara, et al.
Drug Safety|March 22, 2014
Application of a self-controlled case series study to a database study in childrenHanae Ueyama, Shiro Hinotsu, Shiro Tanaka, et al.
Internal Medicine (Tokyo, Japan)|April 7, 2011
Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's diseaseSachiko Nakaoka, Tatsuro Ishizaki, Hisashi Urushihara, et al.
Pageof 6